Prion reduction of red blood cells: impact on component quality

Michael Wiltshire1, Stephen Thomas, Janet Scott

  • 1Components Development Laboratory, NHS Blood and Transplant, Essex, UK. michael.wiltshire@nhsbt.nhs.uk

Transfusion
|December 3, 2009
PubMed
Abstract

Insights

Prion filtration using the P-Capt filter reduces infectious prions in red blood cells (RBCs) without impacting blood group antigens. However, it does cause a significant loss of hemoglobin (Hb).

Area of Science:

  • Transfusion Medicine
  • Biomedical Engineering
  • Prion Disease Research

Background:

  • Infectious prions pose a risk in blood transfusions.
  • A novel P-Capt filter has been developed to remove prions from red blood cells (RBCs).

Purpose of the Study:

  • To evaluate the operational use of the P-Capt filter for prion reduction in RBCs.
  • To assess the quality of filtered RBC components.
  • To determine if prion filtration alters blood group antigen expression.

Main Methods:

  • 272 leukoreduced RBC units were processed using P-Capt filters (top-and-top and bottom-and-top methods).
  • Standard in vitro tests assessed RBC quality post-filtration.
  • Blood group antigen expression, including cryptantigens, was investigated.

Main Results:

  • Prion filtration led to a loss of 7-8 g of hemoglobin and a 6-9% reduction in hematocrit.
  • Hemolysis increased post-filtration but remained within UK specifications.
  • No clinically relevant immunologic changes to the RBC membrane were observed.

Conclusions:

  • P-Capt prion filtration is effective in removing prions without detrimental effects on RBC quality or blood group antigens in vitro.
  • A notable consequence of P-Capt filtration is the reduction in hemoglobin content.

Related Concept Videos

Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Factors Affecting Erythropoiesis01:24

Factors Affecting Erythropoiesis

The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Erythropoiesis01:14

Erythropoiesis

Red blood cells  (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia, and...
Lifecycle of Erythrocytes01:22

Lifecycle of Erythrocytes

Erythrocytes, also known as red blood cells, constantly move through blood capillaries. As a result, they damage their plasma membrane due to the continuous friction. Typically, after 100 to 120 days, erythrocytes become rigid and fragile as they wear out. As they pass through small vessels in the spleen and liver, they can get trapped and break apart into fragments.
The resident phagocytic macrophages deal with these damaged cells by engulfing them and separating their globin and heme groups.
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...